VSN16R - A NOVEL TREATMENT FOR SPASTICITY IN EXPERIMENTAL MULTIPLE SCLEROSIS (2016)
Attributed to:
Biomedical Catalyst – Drug product production, clinical support studies, and phase 1 trial of a new MS drug
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2016-315106.162
Publication URI: http://dx.doi.org/10.1136/jnnp-2016-315106.162
Type: Journal Article/Review
Parent Publication: Journal of Neurology, Neurosurgery & Psychiatry
Issue: 12